189 related articles for article (PubMed ID: 29669167)
1. Scoliosis in Fibrous Dysplasia/McCune-Albright Syndrome: Factors Associated With Curve Progression and Effects of Bisphosphonates.
Berglund JA; Tella SH; Tuthill KF; Kim L; Guthrie LC; Paul SM; Stanton R; Collins MT; Boyce AM
J Bone Miner Res; 2018 Sep; 33(9):1641-1648. PubMed ID: 29669167
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.
Majoor BC; Appelman-Dijkstra NM; Fiocco M; van de Sande MA; Dijkstra PS; Hamdy NA
J Bone Miner Res; 2017 Feb; 32(2):264-276. PubMed ID: 27649526
[TBL] [Abstract][Full Text] [Related]
3. Lesion Expansion in Gnathic Fibrous Dysplasia: Natural History, Indicators of Progression, and Response to Bisphosphonates.
Pan KS; Taylor J; Szymczuk V; Boyce AM
J Bone Miner Res; 2023 Oct; 38(10):1465-1471. PubMed ID: 37477421
[TBL] [Abstract][Full Text] [Related]
4. Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.
Florenzano P; Pan KS; Brown SM; Paul SM; Kushner H; Guthrie LC; de Castro LF; Collins MT; Boyce AM
J Bone Miner Res; 2019 Apr; 34(4):653-660. PubMed ID: 30645769
[TBL] [Abstract][Full Text] [Related]
5. Long Bone Fractures in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History, and Risk Factors.
Geels RES; Meier ME; Saikali A; Tsonaka R; Appelman-Dijkstra NM; Boyce AM
J Bone Miner Res; 2022 Feb; 37(2):236-243. PubMed ID: 34668234
[TBL] [Abstract][Full Text] [Related]
6. Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study.
Meier ME; Appelman-Dijkstra NM; Collins MT; Geels RES; Stanton RP; de Witte PB; Boyce AM; van de Sande MAJ
J Bone Miner Res; 2023 Jul; 38(7):968-975. PubMed ID: 37102469
[TBL] [Abstract][Full Text] [Related]
7. Chiari I Malformation and Basilar Invagination in Fibrous Dysplasia: Prevalence, Mechanisms, and Clinical Implications.
Pan KS; Heiss JD; Brown SM; Collins MT; Boyce AM
J Bone Miner Res; 2018 Nov; 33(11):1990-1998. PubMed ID: 29924878
[TBL] [Abstract][Full Text] [Related]
8. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944
[TBL] [Abstract][Full Text] [Related]
9. Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis.
Leet AI; Magur E; Lee JS; Wientroub S; Robey PG; Collins MT
J Bone Joint Surg Am; 2004 Mar; 86(3):531-7. PubMed ID: 14996879
[TBL] [Abstract][Full Text] [Related]
10. The correlation of specific orthopaedic features of polyostotic fibrous dysplasia with functional outcome scores in children.
Leet AI; Wientroub S; Kushner H; Brillante B; Kelly MH; Robey PG; Collins MT
J Bone Joint Surg Am; 2006 Apr; 88(4):818-23. PubMed ID: 16595472
[TBL] [Abstract][Full Text] [Related]
11. Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.
Bhadada SK; Bhansali A; Das S; Singh R; Sen R; Agarwal A; Mittal BR; Nahar U; Dutta P; Khandelwal N
Indian J Med Res; 2011 May; 133(5):504-9. PubMed ID: 21623035
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
[TBL] [Abstract][Full Text] [Related]
13. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
[TBL] [Abstract][Full Text] [Related]
14. Sinonasal disease in polyostotic fibrous dysplasia and McCune-Albright Syndrome.
DeKlotz TR; Kim HJ; Kelly M; Collins MT
Laryngoscope; 2013 Apr; 123(4):823-8. PubMed ID: 23444264
[TBL] [Abstract][Full Text] [Related]
15. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome.
Zacharin M; O'Sullivan M
J Pediatr; 2000 Sep; 137(3):403-9. PubMed ID: 10969268
[TBL] [Abstract][Full Text] [Related]
16. Risk of developing spontaneous MRONJ in fibrous dysplasia patients treated with bisphosphonates: a systematic review of the literature.
Nadella S; Mupparapu M; Akintoye SO
Quintessence Int; 2022 Jun; 53(7):616-623. PubMed ID: 35674165
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia.
Thomsen MD; Rejnmark L
Calcif Tissue Int; 2014 Apr; 94(4):384-95. PubMed ID: 24390518
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune-Albright syndrome.
Corsi A; Ippolito E; Robey PG; Riminucci M; Boyde A
Skeletal Radiol; 2017 Oct; 46(10):1435-1439. PubMed ID: 28660402
[TBL] [Abstract][Full Text] [Related]
20. Analyses of variable panoramic radiographic characteristics of maxillo-mandibular fibrous dysplasia in McCune-Albright syndrome.
Akintoye SO; Otis LL; Atkinson JC; Brahim J; Kushner H; Robey PG; Collins MT
Oral Dis; 2004 Jan; 10(1):36-43. PubMed ID: 14996293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
